PMC:7463108 / 91507-91700
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T49943 | 85-93 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3151 | 16-21 | Gene | denotes | mBDNF | Gene:12064 |
| 3152 | 77-80 | Gene | denotes | Tat | Gene:6898 |
| 3153 | 176-179 | Gene | denotes | Tat | Gene:6898 |
| 3185 | 85-93 | Chemical | denotes | morphine | MESH:D009020 |
| 3199 | 94-102 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1184 | 0-193 | Sentence | denotes | The addition of mBDNF (50 ng/ml; 72 h) fully protected MSNs against combined Tat and morphine toxicity, but only tended to protect (albeit not significantly) MSNs treated with Tat alone (#)(h). |